Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure
Portfolio Pulse from Vandana Singh
Illumina Inc (NASDAQ:ILMN) is considering divesting its acquisition of Grail if it loses the final appeals in U.S. or European courts. The company completed its $7.1 billion takeover of Grail in August 2021, despite opposition from regulators. If it wins both cases, it will reassess Grail's assets, which might result in integrating or divesting part or the entire unit. The U.S. Federal Trade Commission (FTC) and the EU have ordered Illumina to divest Grail, which Illumina appealed against.
October 12, 2023 | 11:38 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Illumina's stock may be impacted by the potential divestment of Grail. The company's legal battles and regulatory pressures could affect investor sentiment.
The news about Illumina's potential divestment of Grail and the ongoing legal battles with regulators could negatively impact the company's stock in the short term. Investors may be concerned about the uncertainty and potential financial implications.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100